Skip to main content
. 2015 Aug 12;5:13098. doi: 10.1038/srep13098

Figure 3. A panel of 8 miRNAs could distinguish patients with HBV-ACLF from patients with CHB and healthy controls.

Figure 3

The groups of samples are as follows: ACLF, patients with HBV-ACLF; CHB, patients with CHB; CTL, healthy controls.